{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:50:39Z","timestamp":1790985039798,"version":"4.1.0"},"reference-count":125,"publisher":"Informa UK Limited","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Investigational Drugs"],"published-print":{"date-parts":[[2001,7]]},"DOI":"10.1517\/13543784.10.7.1345","type":"journal-article","created":{"date-parts":[[2005,5,4]],"date-time":"2005-05-04T15:34:27Z","timestamp":1115220867000},"page":"1345-1359","source":"Crossref","is-referenced-by-count":17,"title":["Peripheral channelopathies as targets for potassium channel openers"],"prefix":"10.1517","volume":"10","author":[{"given":"Kim","family":"Lawson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J","family":"Dunne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2005,2,24]]},"reference":[{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.9.4759"},{"key":"e_1_2_1_6_1","first-page":"565","article-title":"Potassium ion channels and human disease: phenotypes to drug targets? Cun: Opin","volume":"9","author":"CURRAN ME","year":"1998","unstructured":"CURRAN ME: Potassium ion channels and human disease: phenotypes to drug targets? Cun: Opin. Biotech. (1998) 9:565\u2013572.","journal-title":"Biotech."},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/00019052-199810000-00008"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(97)00029-4"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/18.15.4137"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0896-6273(00)80124-5"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s001250051370"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-978639"},{"key":"e_1_2_1_13_1","doi-asserted-by":"crossref","unstructured":"LAWSON K: Potassium channel activation: a potential therapeutic approach? Pharmacy] Ther. (1996) 70:39\u201363.","DOI":"10.1016\/0163-7258(96)00003-4"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1367-5931(99)80066-0"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02110699"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.2000.278.3.C570"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(00)00866-1"},{"key":"e_1_2_1_18_1","first-page":"857","article-title":"Opening of neuronal K+ channels by flupirtine","volume":"106","author":"KORNHUBER J","year":"1999","unstructured":"KORNHUBER J, MALER M, WILTFANG J, BLEICH S, DEGNER D, RUTHER E: Opening of neuronal K+ channels by flupirtine. Fortschritte der Neurologie Psychiamie (1999) 106:857\u2013867.","journal-title":"Fortschritte der Neurologie Psychiamie"},{"key":"e_1_2_1_19_1","doi-asserted-by":"crossref","unstructured":"CLEMENT JP 4TH KUNJILAR K GONZALEZ G etal.: Association and stoichiometry of Kpap channel subunits. Neuron (1997) 18:827\u2013838.","DOI":"10.1016\/S0896-6273(00)80321-9"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1085\/jgp.110.6.655"},{"key":"e_1_2_1_21_1","first-page":"2269","article-title":"Is there a role for potassium channel openers in neuronal ion channel disorders? Expert Opin","volume":"9","author":"LAWSON K","year":"2000","unstructured":"LAWSON K: Is there a role for potassium channel openers in neuronal ion channel disorders? Expert Opin. Investig. Dugs (2000) 9:2269\u20132280.","journal-title":"Investig. Dugs"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.40.28079"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/19.24.6644"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1067\/mtc.2001.111421"},{"key":"e_1_2_1_25_1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1124\/mol.59.2.225","article-title":"O'ROURKE B, MARBAN E, SEHARASEYON J: Pharmacological comparison of native mitochondrial K(ATP) channels with molecularly defined surface K(ATP) channels","volume":"59","author":"LIU Y","year":"2001","unstructured":"LIU Y, REN G, O'ROURKE B, MARBAN E, SEHARASEYON J: Pharmacological comparison of native mitochondrial K(ATP) channels with molecularly defined surface K(ATP) channels. j Mal. Pharmacal. (2001) 59:225\u2013230.","journal-title":"j Mal. Pharmacal."},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-4388(98)80056-1"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1085\/jgp.112.4.485"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi983040c"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199705293362207"},{"key":"e_1_2_1_30_1","doi-asserted-by":"crossref","unstructured":"VINCENT GM TIMOTHY K FOX J ZHANG L: The inherited long OT syndrome: From ion channel to bedside. Cardial Rev 7:44\u201355.","DOI":"10.1097\/00045415-199901000-00014"},{"key":"e_1_2_1_31_1","doi-asserted-by":"crossref","unstructured":"WANG Q CURRAN ME SPLAWSKI I et al.: Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias (1996) Nat. Genet. 12: 17\u201323.","DOI":"10.1038\/ng0196-17"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.96.9.2778"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.95.3.565"},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-1004(1998)11:2<158::AID-HUMU9>3.0.CO;2-F"},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.97.13.1264"},{"key":"e_1_2_1_36_1","first-page":"290","article-title":"Genomic organization of the KCNQ1 K+ channel gene and identification of C-terminal mutations in the long-QT syndrome Circ","volume":"84","author":"NEYROUD N","year":"1999","unstructured":"NEYROUD N, RICHARD P, VIGNIER N et al.: Genomic organization of the KCNQ1 K+ channel gene and identification of C-terminal mutations in the long-QT syndrome Circ. Res. (1999) 84:290\u2013297.","journal-title":"Res."},{"key":"e_1_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng1197-338"},{"key":"e_1_2_1_38_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.97.2.142"},{"key":"e_1_2_1_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(95)90358-5"},{"key":"e_1_2_1_40_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.5.2208"},{"key":"e_1_2_1_41_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.83.4.415"},{"key":"e_1_2_1_42_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.15.10113"},{"key":"e_1_2_1_43_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.99.17.2290"},{"key":"e_1_2_1_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80728-X"},{"key":"e_1_2_1_45_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002320010045"},{"key":"e_1_2_1_46_1","doi-asserted-by":"crossref","unstructured":"MALL M WISSNER A SCHREIBER R etal.: Role of K(v)LQT1 in cyclic adenosine monophosphate-mediated Cl- secretion in human airway epithelia. Am. I Resp. Cell Mal. Biol. (2000) 23:283\u2013289.","DOI":"10.1165\/ajrcmb.23.3.4060"},{"key":"e_1_2_1_47_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.97.16.1581"},{"key":"e_1_2_1_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8167.1999.tb00665.x"},{"key":"e_1_2_1_49_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.6.706"},{"key":"e_1_2_1_50_1","unstructured":"LEHMANN-HORN F ENGEL AG RICKER K RUDEL R: The periodic paralyses and paramyotonia. In: Myology Engel AG Franzini-Armstong C (Eds.) 2nd Edition McGraw-Hill Publishers New York USA (1994):1303\u20131327."},{"key":"e_1_2_1_51_1","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/3-540-61343-9_9","article-title":"R: Molecular pathophysiology of voltage-gated ion channels","volume":"128","author":"LEHMANN-HORN F","year":"1996","unstructured":"LEHMANN-HORN F, RUDEL R: Molecular pathophysiology of voltage-gated ion channels. Rev Physial Biochem. Pharmacal (1996) 128:195\u2013268.","journal-title":"Rev Physial Biochem. Pharmacal"},{"key":"e_1_2_1_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-8966(97)00435-5"},{"key":"e_1_2_1_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-8966(96)00401-4"},{"key":"e_1_2_1_54_1","first-page":"A249","article-title":"Biophysical changes of skeletal muscle K-ATP channels in K+ depleted rats and pharmacological interventions","volume":"72","author":"TRICARICO D","year":"1997","unstructured":"TRICARICO D, MALLAMACI R, TORTORELLA V, CAMERINO DC: Biophysical changes of skeletal muscle K-ATP channels in K+ depleted rats and pharmacological interventions. Biophys. (1997) 72:A249.","journal-title":"Biophys."},{"key":"e_1_2_1_55_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.42.9.818"},{"key":"e_1_2_1_56_1","first-page":"197","article-title":"The biophysical and pharmacological characteristics of skeletal muscle ATP-sensitive K+ channels are modified in Ktdepleted rat, an animal model of hypokalemic periodic paralysis","volume":"54","author":"TRICARICO D","year":"1998","unstructured":"TRICARICO D, PIERNO S, MALLAMACI R et al: The biophysical and pharmacological characteristics of skeletal muscle ATP-sensitive K+ channels are modified in Ktdepleted rat, an animal model of hypokalemic periodic paralysis. Mal Pharmacal (1998) 54:197\u2013206.","journal-title":"Mal Pharmacal"},{"key":"e_1_2_1_57_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1997.6320"},{"key":"e_1_2_1_58_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI4552"},{"key":"e_1_2_1_59_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.53.7.1556"},{"key":"e_1_2_1_60_1","doi-asserted-by":"publisher","DOI":"10.1042\/cs0910583"},{"key":"e_1_2_1_61_1","first-page":"327","article-title":"Cromakalim (BRL-34915) restores in vitro the membrane-potential of depolarized human skeletal-muscle fibers","volume":"339","author":"SPULER A","year":"1989","unstructured":"SPULER A, LEHMANNHORN F, GRAFE P: Cromakalim (BRL-34915) restores in vitro the membrane-potential of depolarized human skeletal-muscle fibers. Naurryn Schmiedebergs Arch. Pharmacal. (1989) 339:327\u2013331.","journal-title":"Naurryn Schmiedebergs Arch. Pharmacal."},{"key":"e_1_2_1_62_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.880130513"},{"key":"e_1_2_1_63_1","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(200009)48:3<304::AID-ANA4>3.0.CO;2-A"},{"key":"e_1_2_1_64_1","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/j.1939-4640.1993.tb00392.x","article-title":"Characterization of K-currents in cultured human corporal smooth-muscle cells","volume":"14","author":"CHRIST GJ","year":"1993","unstructured":"CHRIST GJ, SPRAY DC, BRINK PR: Characterization of K-currents in cultured human corporal smooth-muscle cells. J. Andra (1993) 14:319\u2013328.","journal-title":"J. Andra"},{"key":"e_1_2_1_65_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijir.3900399"},{"key":"e_1_2_1_66_1","doi-asserted-by":"publisher","DOI":"10.1358\/dot.2000.36.2-3.568791"},{"key":"e_1_2_1_67_1","first-page":"H600\u2013H608","article-title":"Intracorporal injection of hSlo cDNA in rats produces physiologically relevant alterations in penile function","volume":"275","author":"CHRIST GJ","year":"1998","unstructured":"CHRIST GJ, REHMAN J, DAY N et al:Intracorporal injection of hSlo cDNA in rats produces physiologically relevant alterations in penile function. Am. J. Physial (1998) 275:H600\u2013H608.","journal-title":"Am. J. Physial"},{"key":"e_1_2_1_68_1","first-page":"A192","article-title":"K+ channel gene therapy is associated with increased nerve-stimulated intracavernous pressure (ICP) responses despite diminished neuronal innervation following 3-4 months of experimental diabetes in rats","volume":"13","author":"CHRIST GJ","year":"1999","unstructured":"CHRIST GJ, SMITH WL, SANTIZO C et al.: K+ channel gene therapy is associated with increased nerve-stimulated intracavernous pressure (ICP) responses despite diminished neuronal innervation following 3-4 months of experimental diabetes in rats. FASEB J. (1999) 13:A192.","journal-title":"FASEB J"},{"key":"e_1_2_1_69_1","first-page":"A356","article-title":"tiSlo Transcript is locally restricted after a single intracavernous injection of naked hSlo\/pcDNA","volume":"13","author":"DAY NS","year":"2000","unstructured":"DAY NS, MELMAN A, SMITH WL et al.: tiSlo Transcript is locally restricted after a single intracavernous injection of naked hSlo\/pcDNA. FASEB J. (2000)13:A356.","journal-title":"FASEB J."},{"key":"e_1_2_1_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)32573-9"},{"key":"e_1_2_1_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)66199-8"},{"key":"e_1_2_1_72_1","first-page":"837","article-title":"A KATp-channel opener as a potential treatment modality for erectile dysfunction","volume":"83","author":"MOON DG","year":"1999","unstructured":"MOON DG, BYUN HS, KIM JJ: A KATp-channel opener as a potential treatment modality for erectile dysfunction. EN Int. (1999) 83:837\u2013841.","journal-title":"EN Int."},{"key":"e_1_2_1_73_1","unstructured":"PARIVAR K: Systemic PK erectile efficacy and safety of PNU-83757 in patients with erectile dysfunction (ED). OM. Pharmacy]. net: (2000) 67:PII167."},{"key":"e_1_2_1_74_1","first-page":"S158\u2013S162","article-title":"New therapies and delivery mechanisms for treatment of erectile dysfunction","volume":"12","author":"PRYOR JL","year":"2000","unstructured":"PRYOR JL, REDMON B: New therapies and delivery mechanisms for treatment of erectile dysfunction. Intl Impotence Res. (2000) 12:S158\u2013S162.","journal-title":"Intl Impotence Res."},{"key":"e_1_2_1_75_1","unstructured":"MELMAN A CHRIST GJ: Integrative erectile biology: The effects of age and disease on gap junctions and ion channels and their potential value to the treatment of erectile dysfunction. UN Am. (2001)(In press)."},{"key":"e_1_2_1_76_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-4737-2_18"},{"key":"e_1_2_1_77_1","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0022-3565(25)10655-1","article-title":"ZENECA-ZD6169 - A novel Kpap channel opener with in-vivo selectivity for urinary-bladder","volume":"274","author":"HOWE BB","year":"1995","unstructured":"HOWE BB, HALTERMAN TJ, YOCHIM CL et al: ZENECA-ZD6169 - A novel Kpap channel opener with in-vivo selectivity for urinary-bladder. J. Pharmacy]. Exp. Ther. (1995) 274:884\u2013890.","journal-title":"J. Pharmacy]. Exp. Ther."},{"key":"e_1_2_1_78_1","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/S0022-3565(24)38287-4","article-title":"Comparison of the potassium channel openers, WAY-133537, ZD6169, and celikalim on isolated bladder tissue and in vivo bladder instability in rat","volume":"289","author":"WOJDAN A","year":"1999","unstructured":"WOJDAN A, FREEDEN C, WOODS M et al: Comparison of the potassium channel openers, WAY-133537, ZD6169, and celikalim on isolated bladder tissue and in vivo bladder instability in rat. J. Pharmacy]. Exp. Ther. (1999) 289:1410\u20131418.","journal-title":"J. Pharmacy]. Exp. Ther."},{"key":"e_1_2_1_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3565(24)38168-6"},{"key":"e_1_2_1_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(98)00707-0"},{"key":"e_1_2_1_81_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005392-199909010-00095"},{"key":"e_1_2_1_82_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-410X.1997.00257.x"},{"key":"e_1_2_1_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(00)00388-5"},{"key":"e_1_2_1_84_1","doi-asserted-by":"crossref","unstructured":"BUTERA JA ANTANE MM ANTANE SA et al.: Design and SAR of novel potassium channel openers targeted for urge urinary incontinence. 1. N-cyanoguanidine bioisosteres possessing in vivo bladder selectivity. J. Med. Chem (2000) 43:1187\u20131202.","DOI":"10.1021\/jm9905099"},{"key":"e_1_2_1_85_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2299(199705)41:1<10::AID-DDR2>3.0.CO;2-V"},{"key":"e_1_2_1_86_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002320001007"},{"key":"e_1_2_1_87_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-5491.2000.00247.x"},{"key":"e_1_2_1_88_1","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.49.11.1751"},{"key":"e_1_2_1_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-6147(98)01273-5"},{"key":"e_1_2_1_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(85)90403-9"},{"key":"e_1_2_1_91_1","doi-asserted-by":"publisher","DOI":"10.1136\/fn.82.2.F98"},{"key":"e_1_2_1_92_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.107.3.476"},{"key":"e_1_2_1_93_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI9804"},{"key":"e_1_2_1_94_1","doi-asserted-by":"publisher","DOI":"10.1136\/fn.82.2.F79"},{"key":"e_1_2_1_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0005-2736(99)00161-3"},{"key":"e_1_2_1_96_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm1296-1344"},{"key":"e_1_2_1_97_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199703063361005"},{"key":"e_1_2_1_98_1","doi-asserted-by":"publisher","DOI":"10.1038\/79178"},{"key":"e_1_2_1_99_1","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.48.2.408"},{"key":"e_1_2_1_100_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119718"},{"key":"e_1_2_1_101_1","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.50.2.329"},{"key":"e_1_2_1_102_1","first-page":"373","article-title":"Ionic control of beta cell function in nesidioblastosis","volume":"74","author":"LINDLEY KJ","year":"1997","unstructured":"LINDLEY KJ, DUNNE MJ, KANE C et al.: Ionic control of beta cell function in nesidioblastosis. A possible therapeutic role for calcium channel blockade. Arch. Dis. Child (1997) 74:373\u2013378.","journal-title":"A possible therapeutic role for calcium channel blockade. Arch. Dis. Child"},{"key":"e_1_2_1_103_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.051499698"},{"key":"e_1_2_1_104_1","doi-asserted-by":"crossref","unstructured":"SHYNG S-L FERRIGNI T SHEPARD J etal.: Functional analyses of novel mutations in the sulfonylurea receptor 1 associated with persistent hyperinsulinemic hypoglycemia of infancy. Diabetes (1998) 47:1145\u20131151.","DOI":"10.2337\/diabetes.47.7.1145"},{"key":"e_1_2_1_105_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.272.5269.1785"},{"key":"e_1_2_1_106_1","doi-asserted-by":"publisher","DOI":"10.1136\/fn.82.2.F87"},{"key":"e_1_2_1_107_1","first-page":"1352","volume":"338","author":"STANLEY CA","year":"1998","unstructured":"STANLEY CA, LIEU YK, HSU BY etal.: Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene. N Engl. Med. (1998); 338:1352\u20131357.","journal-title":"HSU BY etal.: Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene. N Engl. Med."},{"key":"e_1_2_1_108_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199801223380404"},{"key":"e_1_2_1_109_1","doi-asserted-by":"crossref","unstructured":"EISENBETH GS: Type I diabetes mellitus. A chronic autoimmune disease. N Engl. Med. (1986) 314:1360-1368. Ica LEAHY JL BONNERWEIR S WEIR GC: Beta-cell dysfunction induced by chronic hyperglycemia - current ideas on mechanism of impaired glucose-induced insulin-secretion. Diabetes Care (1992) 15:442\u2013455.","DOI":"10.2337\/diacare.15.3.442"},{"key":"e_1_2_1_110_1","doi-asserted-by":"publisher","DOI":"10.1210\/edrv-15-4-516"},{"key":"e_1_2_1_111_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00703140"},{"key":"e_1_2_1_112_1","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(91)90010-T"},{"key":"e_1_2_1_113_1","doi-asserted-by":"publisher","DOI":"10.2337\/diab.39.8.933"},{"key":"e_1_2_1_114_1","doi-asserted-by":"publisher","DOI":"10.2337\/diab.42.10.1383"},{"key":"e_1_2_1_115_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02342450"},{"key":"e_1_2_1_116_1","doi-asserted-by":"publisher","DOI":"10.3109\/08916939308993326"},{"key":"e_1_2_1_117_1","doi-asserted-by":"publisher","DOI":"10.2337\/diab.45.10.1427"},{"key":"e_1_2_1_118_1","doi-asserted-by":"crossref","unstructured":"PIROTTE B ANTOINE MH DE TULLIO P et al.: A pyridothiadiazine (BPDZ 44) as a new and potent activator of ATP-sensitive K+ channels. Biochem. Pharmacol (1994) 47:1381\u20131386.","DOI":"10.1016\/0006-2952(94)90337-9"},{"key":"e_1_2_1_119_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01956464"},{"key":"e_1_2_1_120_1","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0022-3565(25)12802-4","article-title":"Activation of ATP-dependent K+ channels and inhibition of insulin release: effect of BPDZ 62","volume":"277","author":"LEBRUN P","year":"1996","unstructured":"LEBRUN P, ANTOINE MH, OUEDRAOGO R et al: Activation of ATP-dependent K+ channels and inhibition of insulin release: effect of BPDZ 62. 1 Pharmacol Exp. Ther. (1996) 277:156\u2013162.","journal-title":"1 Pharmacol Exp. Ther."},{"key":"e_1_2_1_121_1","doi-asserted-by":"crossref","unstructured":"KHELILI S DE TULLIO P LEBRUN Pet al.: Preparation and pharmacological evaluation of the R- and S-enantiomers of 3-(2-butylamino)-4H- and 3-(3-methy1-2-butylamino)-4H-pyrido [4 3-el-1 2 4-thiadiazine 1 1-dioxide two tissue selective ATP-sensitive potassium channel openers. Bioorg. Med. Chem (2000) 7:1513\u20131520.","DOI":"10.1016\/S0968-0896(99)00082-6"},{"key":"e_1_2_1_122_1","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.49.7.1131"},{"key":"e_1_2_1_123_1","doi-asserted-by":"publisher","DOI":"10.2337\/diab.43.5.696"},{"key":"e_1_2_1_124_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0026-0495(96)90287-5"},{"key":"e_1_2_1_125_1","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1096\/fasebj.14.3.455","article-title":"MOUSTAID-MOUSSA N: Diazoxide down-regulates leptin and lipid metabolizing enzymes in adipose tissue of Zucker rats","volume":"14","author":"STANDRIDGE M","year":"2000","unstructured":"STANDRIDGE M, ALEMZADEH R, ZEMEL M, KOONTZ J, MOUSTAID-MOUSSA N: Diazoxide down-regulates leptin and lipid metabolizing enzymes in adipose tissue of Zucker rats. FASEB (2000) 14:455\u2013460.","journal-title":"FASEB"},{"key":"e_1_2_1_126_1","first-page":"1911","article-title":"Beneficial effect of diazoxide in obese hyperinsulinemic adults","volume":"83","author":"ALEMZADEH R","year":"1998","unstructured":"ALEMZADEH R, LANGLEY G, UPCHURCH L, SMITH P, SLONIM AE: Beneficial effect of diazoxide in obese hyperinsulinemic adults. J. Chi]. Endo. Metabol. (1998) 83:1911\u20131915.","journal-title":"J. Chi]. Endo. Metabol."},{"key":"e_1_2_1_127_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng1096-152"},{"key":"e_1_2_1_128_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng0696-183"},{"key":"e_1_2_1_129_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng1097-171"}],"container-title":["Expert Opinion on Investigational Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/13543784.10.7.1345","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T21:52:44Z","timestamp":1770933164000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1517\/13543784.10.7.1345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,7]]},"references-count":125,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2001,7]]}},"alternative-id":["10.1517\/13543784.10.7.1345"],"URL":"https:\/\/doi.org\/10.1517\/13543784.10.7.1345","relation":{},"ISSN":["1354-3784","1744-7658"],"issn-type":[{"value":"1354-3784","type":"print"},{"value":"1744-7658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,7]]}}}